Empyrean Capital Partners’s AMN Healthcare AMN Stock Holding History

Empyrean Capital Partners’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-150,000	Closed	-$2.9M	–	97
2025 Q3	$2.9M	Buy	+150,000	New	+$2.93M	0.12%	75

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empyrean Capital Partners's AMN Position: Q4 2025 in Review

Empyrean Capital Partners sold out of AMN Healthcare (AMN) in Q4 2025, closing a stake of 150,000 shares — an estimated $2.9M sold.

Empyrean Capital Partners first reported a position in AMN in Q3 2025 and held it in 1 quarter. The position peaked at $2.9M in Q3 2025. 236 funds tracked by Wall St. Rank hold AMN as of Q4 2025.

Empyrean Capital Partners reported no remaining AMN Healthcare position as of Q4 2025 after selling out during the quarter.
Empyrean Capital Partners sold 150,000 AMN Healthcare shares in Q4 2025, an estimated $2.9M.
Empyrean Capital Partners first reported a position in AMN Healthcare in Q3 2025 and held it in 1 quarter.
Empyrean Capital Partners's AMN Healthcare position peaked at $2.9M in Q3 2025.
236 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2025.

Based on Empyrean Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.